BioNxt Solutions Inc. (BNXT)

BRIEF

published on 01/21/2025 at 09:10, 1 day 23 hours ago

Déménagement stratégique de BioNxt vers le laboratoire Gen-Plus à Munich

Innovation Pharmaceutique Solutions BioNxt Systèmes D'administration De Médicaments Laboratoire Gen-Plus Expansion De La R&D
BRIEF

published on 01/21/2025 at 09:10, 1 day 23 hours ago

BioNxt's Strategic Move to Gen-Plus Laboratory in Munich

Pharmaceutical Innovation R&D Expansion BioNxt Solutions Drug Delivery Systems Gen-Plus Laboratory
PRESS RELEASE

published on 01/21/2025 at 09:05, 1 day 23 hours ago

BioNxt Accelerates R&D with Move to Gen-Plus Laboratory in Munich, Germany, Expanding Drug Delivery Research Capabilities
BioNxt Solutions Inc. relocates R&D activities to Gen-Plus CRDO in Munich, Germany, enhancing capabilities and fostering collaborations in drug delivery systems, neurodegenerative therapeutics, and biomedical tech

BioNxt Solutions Inc. Munich R&D Activities Drug Delivery Systems Gen-Plus CRDO
BRIEF

published on 12/19/2024 at 09:10, 1 month 3 days ago

BioNxt Solutions Expands Patent Portfolio for Drug Delivery Innovations

Multiple Sclerosis BioNxt Solutions Sublingual Delivery Patent Expansion Drug Innovation
BRIEF

published on 12/19/2024 at 09:10, 1 month 3 days ago

BioNxt Solutions élargit son portefeuille de brevets pour ses innovations en matière d'administration de médicaments

Sclérose En Plaques Innovation Pharmaceutique Solutions BioNxt Extension Du Brevet Administration Sublinguale
PRESS RELEASE

published on 12/19/2024 at 09:05, 1 month 3 days ago

BioNxt Solutions Expands Patent Protection for Drug Delivery Innovations Backed by Positive IPRP
BioNxt Solutions Inc. expands its intellectual property portfolio with new international patents for sublingual delivery technologies targeting autoimmune neurodegenerative diseases. The company aims to bring patient-friendly therapies to individuals affected by these diseases

BioNxt Solutions Inc. Intellectual Property Patents Autoimmune Neurodegenerative Diseases Sublingual Delivery Technologies
BRIEF

published on 12/09/2024 at 09:10, 1 month 13 days ago

BioNxt Solutions Advances BNT23001 for MS Treatment

Clinical Trials Drug Development Multiple Sclerosis BioNxt Solutions BNT23001
BRIEF

published on 12/09/2024 at 09:10, 1 month 13 days ago

BioNxt Solutions développe le BNT23001 pour le traitement de la sclérose en plaques

Essais Cliniques Sclérose En Plaques Développement De Médicaments Solutions BioNxt BNT23001
PRESS RELEASE

published on 12/09/2024 at 09:05, 1 month 13 days ago

BioNxt Solutions Reports Progress on BNT23001 Development for Multiple Sclerosis Treatment
BioNxt Solutions Inc. achieves key milestones in the development of BNT23001, a sublingual thin-film formulation of Cladribine for Multiple Sclerosis treatment, paving the way for clinical trials and regulatory submissions in 2025

Clinical Trials BioNxt Solutions Inc. Multiple Sclerosis Sublingual Thin-Film BNT23001
BRIEF

published on 12/02/2024 at 09:10, 1 month 20 days ago

BioNxt Solutions développe un film mince sublingual pour le sémaglutide

Solutions BioNxt Conformité Des Patients Semaglutide Couche Mince Sublinguale Innovation Dans L'administration Des Médicaments

1 2 ... 8

Published on 01/23/2025 at 06:00, 2 hours 14 minutes ago

The Now Corporation (OTC:NWPN) In Conjunction With Subsidiary Green Rain Solar Inc., Launch a Visionary Video Showcasing Solar Energy Solutions
Published on 01/23/2025 at 02:30, 5 hours 44 minutes ago

Armory Mining Corp. Closes LIFE Offering
Published on 01/23/2025 at 02:00, 6 hours 14 minutes ago

West Mining Options Kena Property to Upside Gold Corp
Published on 01/23/2025 at 02:00, 6 hours 14 minutes ago

Inspire Veterinary Partners Announces 1-for-25 Reverse Stock Split
Published on 01/23/2025 at 00:00, 8 hours 14 minutes ago

Onco-Innovations Enters into LOI with Inka Health to Implement AI Technology Toward Cancer Detection and Drug Development

View all ACCESSWIRE

Published on 01/23/2025 at 08:00, 13 minutes ago

R.E.A. Holdings plc: Trading update
Published on 01/23/2025 at 08:00, 13 minutes ago

SWEF: December 2024 NAV
Published on 01/23/2025 at 08:00, 13 minutes ago

Transaction in Own Shares
Published on 01/23/2025 at 08:00, 13 minutes ago

Operational & Corporate Update
Published on 01/23/2025 at 08:00, 13 minutes ago

Dalata Hotel Group PLC: POS-Transaction in Own Shares

View all EQS

Published on 01/23/2025 at 07:00, 1 hour 14 minutes ago

2024 : Une nouvelle année de croissance. Chiffre d'affaires 880 M€ (+10 %)
Published on 01/23/2025 at 07:00, 1 hour 14 minutes ago

2024: Another year of growth. Annual sales: €880m (+10%)
Published on 01/22/2025 at 17:45, 14 hours 29 minutes ago

BILAN SEMESTRIEL DU CONTRAT DE LIQUIDITE CONTRACTE AVEC LA SOCIETE DE BOURSE GILBERT DUPONT
Published on 01/22/2025 at 17:14, 15 hours ago

VOGO : Bilan semestriel du contrat de liquidité contracté avec le Crédit Industriel et Commercial.
Published on 01/22/2025 at 07:04, 1 day 1 hour ago

Gimv launches strategy to accelerate its growth

View all LES ECHOS COMFI WIRE

News